• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.13% Nasdaq Up 0.57%

    Gilead Sciences Inc. (GILD)

    -NasdaqGS
    117.08 Up 1.63(1.41%) Jun 30, 4:00PM EDT
    |Pre-Market : 118.20 Up 1.12 (0.96%) 8:39AM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:115.46
    Open:117.29
    Bid:118.07 x 100
    Ask:118.10 x 1500
    1y Target Est:122.00
    Beta:0.87
    Next Earnings Date:27-Jul-15GILD Earnings announcement
    Day's Range:116.78 - 118.30
    52wk Range:84.75 - 123.37
    Volume:11,380,563
    Avg Vol (3m):11,009,400
    Market Cap:172.06B
    P/E (ttm):13.35
    EPS (ttm):8.77
    Div & Yield:1.72 (1.40%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Related Video

    Comparison

    Symbol% ChgMkt Cap
    GILDUp 1.41%172.06B
    GSKDown 0.90%100.58B
    PFEDown 0.18%206.47B
    RHHBYDown 0.68%N/A

    Key Statistics

    Forward P/E (1 yr):10.61
    P/S (ttm):6.17
    Ex-Dividend Date:12-Jun-15

    Analysts

    Annual EPS Est (Dec-15) :10.77
    Quarterly EPS Est (Jun-15) :2.64
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):0.82

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical need in North America, South America, Europe, and the Asia-Pacific. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback